Alliance Pharma PLC (STU:DVL)
€ 0.52 0.005 (0.97%) Market Cap: 296.49 Mil Enterprise Value: 400.78 Mil PE Ratio: 0 PB Ratio: 1.12 GF Score: 75/100

Full Year 2018 Alliance Pharma PLC Earnings Call Transcript

Mar 26, 2019 / 11:00AM GMT
Release Date Price: €0.78 (+6.85%)
Peter Jonathan Butterfield
Alliance Pharma plc - CEO & Executive Director

Okay, good morning, everybody. I think we'll get going. For those of you that don't know me, I'm Pete Butterfield, CEO of Alliance. I'm joined by Andrew Franklin, CFO of Alliance. And great to see so many of you here actually, and thank you for joining us for our full year results presentation. So today's meeting is being webcast. So at the end of the presentation, if you have any questions, there'll be a roving mic for you to ask any questions that you have, but to those joining us online, big welcome, and thank you for your interest in the company as well.

So let me take you through the presentation. Obviously, I'll run through the disclaimer all in there. We're going to take you through business overview first, just to sort of ground you, remind you of where Alliance is and the journey that we've been on over the last 3 or 4 years, deep dive into the financials with Andrew, then I'm going to give you a bit of an outlook for the business, which is something we haven't done before at these types of presentations, but

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot